The new generation of gene editors

Also: Apple claims new AirPod hearing aid feature is 'clinical grade.' Is it?

October 31, 2024 Check out STAT+

Sponsored By

Photo illustration: Christine Kao/STAT; Photos: Michelle Fredricks, Peggy Peterson, Suzanne Kreiter/Globe Staff STAT+ | These 10 scientists are leading a new generation of gene editors developing CRISPR medicines STAT series looks at movers and shakers in the life sciences. Here are 10 scientists developing new therapeutic applications of CRISPR By Megan Molteni Limiting sugar in infancy is tied to less diabetes and hypertension in adulthood A natural experiment shows that children born before sugar rationing ended in the U.K. had lower health risks as adults. By Elizabeth Cooney STAT+ | Teva fined $503 million for disparaging a rival and using patents to thwart competition This marked the second time that the European Commission has successfully concluded a case against a drugmaker for disparaging a rival. By Ed Silverman MARK RALSTON/AFP via Getty Images Should race be used in clinical algorithms? How one doctor's research is helping shape policy STAT Wunderkind James Diao's research on race and clinical decisions draws on both data and the perspectives of patients. By Katie Palmer STAT+ | Capricor and the FDA: A daring, risky filing strategy The company is leveraging the precedent set by Sarepta Therapeutics with its plans for a stem cell therapy for patients with Duchenne muscular dystrophy. By Adam Feuerstein STAT+ | Small mid-stage trial suggests targeted magnetic pulses to brain could slow Alzheimer's Alzheimer's patients who received TMS saw a 44% slowing of disease progression after a year compared to those given a sham procedure By Jonathan Wosen Mary Conlon/AP STAT+ | Apple claims new AirPod hearing aid feature is 'clinical grade.' Is it? With its new hearing health features, Apple has once again blurred the line between medical devices and consumer gadgets By Mario Aguilar

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser